Current authoritative sources
Sanofi clinical-trial listing
Official current study overview for “Fabry Disease Registry & Pregnancy Sub-registry,” NCT00196742.
Open Sanofi study pageClinicalTrials.gov
Public study record with current status, eligibility language, and sponsor information.
Open study recordLinks open external websites. Verify their domain and privacy policies before sharing information.
Archived 2015 contact reference
Historical only—do not assume these details are current.
| Region | Archived contact |
|---|---|
| Global & North America | Genzyme, Cambridge, Massachusetts 1-800-745-4447 ext. 15500 fabryregistry@genzyme.com |
| Europe, Middle East & Africa | Genzyme Europe BV, Naarden, Netherlands +31-35-699-1232 Europe@fabryregistry.com |
| Latin America | Genzyme do Brasil Ltda., Rio de Janeiro +55-21-2156-9950 |
| Asia-Pacific | Genzyme Asia Pacific, Singapore +65 62263836 |
Do not email health records to archived addresses.
Confirm current contacts through official Sanofi study channels and use secure, authorized systems for any clinical information.